Cassandra Berry

410 total citations
15 papers, 290 citations indexed

About

Cassandra Berry is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Cassandra Berry has authored 15 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Cassandra Berry's work include Influenza Virus Research Studies (6 papers), Respiratory viral infections research (6 papers) and HIV Research and Treatment (4 papers). Cassandra Berry is often cited by papers focused on Influenza Virus Research Studies (6 papers), Respiratory viral infections research (6 papers) and HIV Research and Treatment (4 papers). Cassandra Berry collaborates with scholars based in Australia, United States and Switzerland. Cassandra Berry's co-authors include David Nolan, Nurshahidah Ali, Gérrard Eddy Jai Poinern, Derek Fawcett, Martyn A. French, Sònia Fernández, Alison Castley, A. Castley, Lilian Cha and R. Krueger and has published in prestigious journals such as PLoS ONE, Cytokine & Growth Factor Reviews and Human Vaccines & Immunotherapeutics.

In The Last Decade

Cassandra Berry

15 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cassandra Berry Australia 9 80 77 72 69 54 15 290
Brooke Grasperge United States 11 121 1.5× 89 1.2× 85 1.2× 122 1.8× 40 0.7× 24 380
Phong T. Ho United States 6 206 2.6× 62 0.8× 39 0.5× 146 2.1× 29 0.5× 6 329
Weizhong Guo China 12 256 3.2× 196 2.5× 96 1.3× 123 1.8× 38 0.7× 16 474
Birgitte Rønde Hansen Denmark 14 59 0.7× 33 0.4× 186 2.6× 146 2.1× 7 0.1× 39 484
Anthony Cook United States 9 27 0.3× 35 0.5× 151 2.1× 192 2.8× 34 0.6× 16 423
Zachary Greenberg United States 11 87 1.1× 68 0.9× 62 0.9× 92 1.3× 72 1.3× 20 448
Efrat Kochba United States 15 26 0.3× 244 3.2× 80 1.1× 80 1.2× 41 0.8× 20 701
Hema Ramachandran Malaysia 10 110 1.4× 102 1.3× 38 0.5× 49 0.7× 40 0.7× 14 414
Mario E.A.F. Alves United States 16 21 0.3× 21 0.3× 76 1.1× 60 0.9× 24 0.4× 26 737
Zhuang Wan United States 13 109 1.4× 114 1.5× 81 1.1× 77 1.1× 24 0.4× 26 406

Countries citing papers authored by Cassandra Berry

Since Specialization
Citations

This map shows the geographic impact of Cassandra Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassandra Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassandra Berry more than expected).

Fields of papers citing papers by Cassandra Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cassandra Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassandra Berry. The network helps show where Cassandra Berry may publish in the future.

Co-authorship network of co-authors of Cassandra Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Cassandra Berry. A scholar is included among the top collaborators of Cassandra Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cassandra Berry. Cassandra Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Berry, Cassandra, et al.. (2022). How a mRNA COVID-19 Vaccine works inside a Cell: A Virtual Reality Serious Game. 1–6. 1 indexed citations
2.
Berry, Cassandra. (2017). A Technique for Inspiring Scientific Inquiry Using a Creative Scenario. The American Biology Teacher. 79(8). 671–677. 2 indexed citations
3.
Berry, Cassandra. (2017). Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?. Human Vaccines & Immunotherapeutics. 14(3). 796–799. 16 indexed citations
4.
Castley, Alison, et al.. (2016). Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PLoS ONE. 11(6). e0158169–e0158169. 30 indexed citations
5.
Berry, Cassandra. (2016). Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System.. Cytokine & Growth Factor Reviews. 31. 83–90. 12 indexed citations
6.
Berry, Cassandra. (2015). Towards a Universal Influenza Virus Vaccine Eliciting Broadly Neutralising Haemagglutinin Antibodies. Journal of Vaccines & Vaccination. 6(6). 2 indexed citations
7.
8.
Penhale, W.J., et al.. (2014). Modulation of Innate Immune Responses by Influenza-Specific Ovine Polyclonal Antibodies Used for Prophylaxis. PLoS ONE. 9(2). e89674–e89674. 13 indexed citations
9.
Strickland, Deborah H., Vanessa S. Fear, Graeme R. Zosky, et al.. (2014). Persistent and Compartmentalised Disruption of Dendritic Cell Subpopulations in the Lung following Influenza A Virus Infection. PLoS ONE. 9(11). e111520–e111520. 23 indexed citations
10.
Berry, Cassandra, W.J. Penhale, & Mark Y. Sangster. (2014). Passive Broad-Spectrum Influenza Immunoprophylaxis. PubMed. 2014. 1–9. 5 indexed citations
11.
Cha, Lilian, Cassandra Berry, David Nolan, et al.. (2014). Interferon‐alpha, immune activation and immune dysfunction in treated HIV infection. Clinical & Translational Immunology. 3(2). e10–e10. 48 indexed citations
12.
Poinern, Gérrard Eddy Jai, et al.. (2013). Engineering a Biocompatible Scaffold with Either Micrometre or Nanometre Scale Surface Topography for Promoting Protein Adsorption and Cellular Response. International Journal of Biomaterials. 2013. 1–16. 74 indexed citations
13.
Berry, Cassandra. (2012). Vaccine Control of Avian Influenza H5N1 in Poultry: Need for a Positive Marker. Journal of Vaccines & Vaccination. 4(1). 5 indexed citations
14.
Berry, Cassandra, Paul J. Hertzog, & Niamh E. Mangan. (2012). Interferons as Biomarkers and Effectors: Lessons Learned from Animal Models. Biomarkers in Medicine. 6(2). 159–176. 7 indexed citations
15.
Bayer, Wibke, Matthias Tenbusch, Ghulam Nabi, et al.. (2011). Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology. 8(1). 75–75. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brooke Grasperge Breakdown of academic impact, for papers by Phong T. Ho Breakdown of academic impact, for papers by Weizhong Guo Breakdown of academic impact, for papers by Birgitte Rønde Hansen Breakdown of academic impact, for papers by Anthony Cook Breakdown of academic impact, for papers by Zachary Greenberg Breakdown of academic impact, for papers by Efrat Kochba Breakdown of academic impact, for papers by Hema Ramachandran Breakdown of academic impact, for papers by Mario E.A.F. Alves Breakdown of academic impact, for papers by Zhuang Wan
Rankless by CCL
2026